Depression screening: A natural role for pharmacists
May 15th 2011Depression is a disease like any other. The pharmacist's task is to keep depression patients educated about their disease and their medications, and to stress the importance of adherence to medication. But before that, depression screening may be Job 1.
AHA updates CVD prevention guidelines for women
May 12th 2011The American Heart Association recently released its updated cardiovascular disease prevention guidelines for women. The guidelines emphasize practical medical advice that works in the ?real world? rather than on findings primarily observed in clinical research.
Johnson & Johnson finds traces of fungicide in HIV drug Prezista
May 11th 2011BANGALORE (Reuters) - Johnson & Johnson unit Janssen said it was in discussions with regulatory authorities in Europe and Canada to address trace amounts of a fungicide found in certain lots of its HIV drug Prezista (darunavir).
FDA approves first meningococcal vaccine for infants and toddlers
May 10th 2011FDA approved the use of meningococcal (A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine (Menactra, Sanofi Pasteur) in children aged as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
Opioid-related mortality associated with daily dose for nonmalignant pain
May 10th 2011A daily dose of opioids for nonmalignant pain is strongly associated with opioid-related mortality, and doses of 200 mg or more of morphine or equivalent are associated with a particularly high risk, according to a recent study published in the April issue of Archives of Internal Medicine.
Decrease in breast cancer risk persists in estrogen trial follow-up
April 28th 2011Postmenopausal women who were evaluated after taking conjugated equine estrogen had neither an increased nor decreased risk of coronary heart disease, and a decrease in breast cancer risk persisted, according to a post-intervention follow-up of the Women?s Health Initiative Estrogen-Alone Trial, published in the Journal of the American Medical Association.
Vaginal progesterone gel reduces rate of preterm birth
April 19th 2011Vaginal progesterone administered from the mid-trimester of pregnancy until term in women with a premature cervical shortening, as confirmed by transvaginal ultrasound, significantly reduced the rate of preterm birth before 33 weeks gestation, according to a phase 3 study published online in Ultrasound in Obstetrics & Gynecology.
AHA presents guidelines for managing manifestations of VTE
April 19th 2011There are several therapies in addition to blood thinners that physicians should consider when managing patients with deep vein thrombosis, according to a new scientific statement from the American Heart Association. The statement is published online in Circulation.
Antibiotic stewardship: Perspective on clinical decision-making
April 15th 2011Excessive use of antibiotics has led to the development of drug-resistant pathogens. A sharp decline in development of new antibiotics has limited antimicrobial treatment options. Consequently, as infections become more difficult to treat, patient outcomes may worsen and healthcare costs may rise.
Tiotropium superior to salmeterol in preventing exacerbations in COPD
April 12th 2011The anticholinergic drug tiotropium is more effective than the Β2-agonist salmeterol in preventing exacerbations in patients with moderate-to-very-severe chronic obstructive pulmonary disease, according to a multicenter European study published in the New England Journal of Medicine.
Rheumatic disease patients may require 2 doses of flu vaccine
April 12th 2011Patients with inflammatory rheumatic disease may need 2 doses of adjuvanted split influenza A vaccine to elicit the same antibody response as healthy individuals, reported a recent Swiss study published in Arthritis & Rheumatism.
Suppressive therapy manages clopidogrel hypersensitivity
April 12th 2011Clopidogrel hypersensitivity, which affects 6% of patients, can be successfully treated using short-course corticosteroids and antihistamines without interrupting drug therapy, reported researchers at Jefferson Medical College in Philadelphia.
Combination of ACEI and ARB therapy increases renal risks in elderly
April 12th 2011Combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers is associated with increased risk of adverse renal outcomes, according to a recent study published in the Canadian Medical Association Journal.
High-dose clopidogrel does not reduce mortality after PCI
April 7th 2011The use of high-dose clopidogrel compared with use of standard-dose clopidogrel does not reduce the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or stent thrombosis among patients with high on-treatment reactivity after percutaneous coronary intervention with drug-eluting stents, according to a recent multicenter study published in the Journal of the American Medical Association.